Loading company details...
Beta
Latest Form 4 (Sep 3, 2026): Akinbolade Oyegunwa (EVP, CIO & CTO): Grant/Award of 750 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Akinbolade Oyegunwa, EVP, CIO & CTO | Grant/Award | 750 | n/a |
| Sep 3, 2026 | Jonathan C. Meltzer, EVP, COO | Grant/Award | 900 | n/a |
| Sep 3, 2026 | Bryan T. Vaughn, EVP and President, Diagnostics | Grant/Award | 1,500 | n/a |
| Sep 3, 2026 | Brian J. Caveney, EVP, Pres of BLS, CMO & CSO | Grant/Award | 3,000 | n/a |
| Aug 18, 2026 | Kerrii B. Anderson | Sale | 3,000 | $954.1K |
| Aug 12, 2026 | Adam H. Schechter, President & CEO | Sale | 4,669 | $1.50M |
| Aug 6, 2026 | Amy B. Summy, EVP, Chief Marketing Officer | Sale | 924 | $283.4K |
| Aug 5, 2026 | Peter J. Wilkinson, SVP, Chief Accounting Officer | Sale | 82 | $25.4K |
| Jul 6, 2026 | Kathryn W. Kyle, EVP, Chief Legal Officer | Exercise/Conversion | 256 | n/a |
| Jul 6, 2026 | Bryan T. Vaughn, EVP and President, Diagnostics | Exercise/Conversion | 327 | n/a |